Literature DB >> 10678837

Convergent solutions to binding at a protein-protein interface.

W L DeLano1, M H Ultsch, A M de Vos, J A Wells.   

Abstract

The hinge region on the Fc fragment of human immunoglobulin G interacts with at least four different natural protein scaffolds that bind at a common site between the C(H2) and C(H3) domains. This "consensus" site was also dominant for binding of random peptides selected in vitro for high affinity (dissociation constant, about 25 nanomolar) by bacteriophage display. Thus, this site appears to be preferred owing to its intrinsic physiochemical properties, and not for biological function alone. A 2.7 angstrom crystal structure of a selected 13-amino acid peptide in complex with Fc demonstrated that the peptide adopts a compact structure radically different from that of the other Fc binding proteins. Nevertheless, the specific Fc binding interactions of the peptide strongly mimic those of the other proteins. Juxtaposition of the available Fc-complex crystal structures showed that the convergent binding surface is highly accessible, adaptive, and hydrophobic and contains relatively few sites for polar interactions. These are all properties that may promote cross-reactive binding, which is common to protein-protein interactions and especially hormone-receptor complexes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678837     DOI: 10.1126/science.287.5456.1279

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  200 in total

1.  The use of mRNA display to select high-affinity protein-binding peptides.

Authors:  D S Wilson; A D Keefe; J W Szostak
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Identification of protein oligomerization states by analysis of interface conservation.

Authors:  A H Elcock; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

3.  Catalytic and binding poly-reactivities shared by two unrelated proteins: The potential role of promiscuity in enzyme evolution.

Authors:  L C James; D S Tawfik
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

Review 4.  Multiple diverse ligands binding at a single protein site: a matter of pre-existing populations.

Authors:  Buyong Ma; Maxim Shatsky; Haim J Wolfson; Ruth Nussinov
Journal:  Protein Sci       Date:  2002-02       Impact factor: 6.725

5.  One site fits both: a model for the ternary complex of folate + NADPH in R67 dihydrofolate reductase, a D2 symmetric enzyme.

Authors:  E E Howell; U Shukla; S N Hicks; R D Smiley; L A Kuhn; M I Zavodszky
Journal:  J Comput Aided Mol Des       Date:  2001-11       Impact factor: 3.686

6.  Evolutionary transition pathways for changing peptide ligand specificity and structure.

Authors:  U Hoffmüller; T Knaute; M Hahn; W Höhne; J Schneider-Mergener; A Kramer
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

7.  Binding of small molecules to an adaptive protein-protein interface.

Authors:  Michelle R Arkin; Mike Randal; Warren L DeLano; Jennifer Hyde; Tinh N Luong; Johan D Oslob; Darren R Raphael; Lisa Taylor; Jun Wang; Robert S McDowell; James A Wells; Andrew C Braisted
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-11       Impact factor: 11.205

8.  Structural basis for recognition by an in vitro evolved affibody.

Authors:  Martin Högbom; Malin Eklund; Per-Ake Nygren; Pär Nordlund
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

Review 9.  Exploring privileged structures: the combinatorial synthesis of cyclic peptides.

Authors:  Douglas A Horton; Gregory T Bourne; Mark L Smythe
Journal:  J Comput Aided Mol Des       Date:  2002 May-Jun       Impact factor: 3.686

10.  How do two unrelated antibodies, HyHEL-10 and F9.13.7, recognize the same epitope of hen egg-white lysozyme?

Authors:  Jaume Pons; Jennifer R Stratton; Jack F Kirsch
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.